A review of update clinical results of carbon ion radiotherapy

H Tsujii, T Kamada - Japanese journal of clinical oncology, 2012 - academic.oup.com
Among various types of ion species, carbon ions are considered to have the most balanced,
optimal properties in terms of possessing physically and biologically effective dose …

Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature

L Budäus, M Bolla, A Bossi, C Cozzarini, J Crook… - European urology, 2012 - Elsevier
CONTEXT: Prostate cancer (PCa) patients have many options within the realms of surgery
or radiation therapy (RT). Technical advancements in RT planning and delivery have …

[HTML][HTML] Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer

WR Lee, JJ Dignam, MB Amin, DW Bruner… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Purpose Conventional radiotherapy (C-RT) treatment schedules for patients with prostate
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …

[HTML][HTML] Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials

CR King, D Freeman, I Kaplan, D Fuller… - Radiotherapy and …, 2013 - Elsevier
Purpose The effectiveness of stereotactic body radiotherapy (SBRT) for localized prostate
cancer is tested. Methods and materials A total of 1100 patients with clinically localized …

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority …

S Aluwini, F Pos, E Schimmel, S Krol… - The Lancet …, 2016 - thelancet.com
Background Several studies have reported a low α to β ratio for prostate cancer, suggesting
that hypofractionation could enhance the biological tumour dose without increasing …

Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer

CR King, JD Brooks, H Gill, JC Presti Jr - International Journal of Radiation …, 2012 - Elsevier
PURPOSE: Hypofractionated radiotherapy has an intrinsically different normal tissue and
tumor radiobiology. The results of a prospective trial of stereotactic body radiotherapy …

[HTML][HTML] Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised …

D Dearnaley, I Syndikus, G Sumo, M Bidmead… - The lancet …, 2012 - thelancet.com
Background Prostate cancer might have high radiation-fraction sensitivity, implying a
therapeutic advantage of hypofractionated treatment. We present a pre-planned preliminary …

Prostate alpha/beta revisited–an analysis of clinical results from 14 168 patients

A Dasu, I Toma-Dasu - Acta Oncologica, 2012 - Taylor & Francis
Purpose. To determine the dose response parameters and the fractionation sensitivity of
prostate tumours from clinical results of patients treated with external beam radiotherapy …

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority …

S Aluwini, F Pos, E Schimmel, E van Lin, S Krol… - The Lancet …, 2015 - thelancet.com
Background In 2007, we began the randomised phase 3 multicentre HYPRO trial to
investigate the effect of hypofractionated radiotherapy compared with conventionally …

Dose–volume effects for normal tissues in external radiotherapy: pelvis

C Fiorino, R Valdagni, T Rancati… - Radiotherapy and …, 2009 - Elsevier
A great deal of quantitative information regarding the dose–volume relationships of pelvic
organs at risk has been collected and analysed over the last 10 years. The need to improve …